Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)
Clinical trial NCT00486265 · TERMINATED
Trial details
- NCT number
- NCT00486265
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.